XML 32 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note N - Income Taxes
12 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
NOTE
 N — INCOME TAXES
 
       
Due to Milestone Scientific's history of operating losses, a full valuation allowances have been provided for all of Milestone Scientific's deferred tax assets At
December 31,
 
2017
and
2016,
no
recognition was given to the utilization of the remaining net operating loss carryforwards in each of these periods.
 
In accordance with ASU
2015
-
17,
Income Taxes, deferred tax assets and liabilities have been classified, and treated retrospectively, as non-current.  Deferred tax attributes resulting from differences between financial accounting amounts and tax bases of assets and liabilities at
December 31, 2017
and
2016
are as follows: 
 
   
2017
   
2016
 
                 
                 
Allowance for doubtful accounts-short term
  $
3,000
    $
4,000
 
Warranty reserve
   
20,000
     
36,000
 
Capital Gains    
45,000
     
 
 
Deferred officers compensation
   
636,000
     
395,000
 
Depreciation and Amortization
   
181,000
     
135,000
 
Deferred revenue    
478,000
     
 
 
Net operating loss carryforward
   
15,116,000
     
18,456,000
 
Subtotal
   
16,479,000
     
19,026,000
 
Valuation allowance
  $
(16,479,000
)   $
(19,026,000
)
 
       
The deferred tax asset, before valuation allowance, has been calculated on rates anticipated to be effect when the temporary differences reverse.
  Accordingly, based on the change in Federal tax rates promulgated in
December 2017,
effective
January 1, 2018,
the Company utilized a Federal rate of
21%
and accordingly existing deferred tax assets upon the tax law act being signed into law on
December 22, 2017,
the Company revalued its deferred tax assets which resulted in a tax provision charge of
$8,677,000,
offset by a corresponding decrease in the valuation allowance. 
As of
December 31, 2017,
federal net operating loss carryforwards are approximately
$60,000,000.
  As of
December 31, 2016,
and Milestone Scientific has federal net operating loss carryforwards of approximately
$56,530,000,
which is comprised solely of losses attributable Milestone Scientific and its subsidiaries.  Net operating losses will be available to offset future taxable income, if any, through
December 2037.
As of
December 31, 2017,
state net operating losses were approximately
$24,500,000.
As of
December 31, 2016
Milestone, Scientific has state net operating loss carryforwards of approximately
$22,942,000.
  Net operating losses will be available to offset future taxable income, if any, through
December 2037.
 
  
The utilization of Milestone Scientific's net operating losses
may
be subject to a substantial limitation due to the "change of ownership provisions" under Section
382
of the Internal Revenue Code and similar state provisions. Such limitation
may
result in the expiration of the net operating loss carry forwards before their utilization. Milestone Scientific has established a
100%
valuation allowance for all its deferred tax assets due to uncertainty as to their future realization.
 
 
As of
December 31, 2017,
and
2016,
state tax liability was approximately
$18,339
and
$13,000
respectively. Such expense was recognized in the accompanying consolidated financial statements.
 
A reconciliation of the statutory tax rates for the years ended
December 31,
is as follows:
   
 
 
   
2017
   
2016
 
Statutory rate
   
34
%    
34
%
State income tax - all states
   
6
%    
6
%
Non-deductible Stock based compensation    
-
     
3
%
Deferred provision for effect of change in Federal    
164
%    
-
 
     
204
%    
43
%
Valuation allowance    
(204
%)    
(43
%)
Effective tax rate
   
0
%    
0
%
 
 
        Accounting for uncertainties in income taxes prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return, and provides guidance on derecognition, classification, interest and penalties, disclosure and transition. At
December 31, 2017,
and
2016,
we had
no
uncertain tax positions that required recognition in the consolidated financial statements. Milestone Scientific's policy is to recognize interest and penalties on unrecognized tax benefits in income tax expense in the Statements of Operations.
No
interest and penalties are present for periods open. Tax returns for the
2014,
2015,
and
2016
years are subject to audit by federal and state jurisdictions.